$CURR Taken from the latest PR! CEO Nancy Duitch, “I look forward to additional non-dilutive capital infusions and am very excited about the new technologies Rob Davidson & his team are working on for the Company” https://finance.yahoo.com/news/cure-pharmaceutical-reports-second-quarter-100000381.html